HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 601-612 of 1,811
Drug study icon
CompletedNCT00485628

Safety Study in Outpatient Japanese Children With ADHD

What is this study about?

This study evaluated the safety of Atomoxetine Hydrochloride for people with ADHD.

This study has finished and is no longer accepting participants.

In Tokyo
ADHDMedication studyAges 6–17
Countries
Japan
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT00640185

Safety study of ABT-089 in ADHD

What is this study about?

This study evaluated the safety and effectiveness of ABT-089 for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Lafayette
ADHDMedication studyAges 18–60
Countries
United States
Sponsor
AbbVie (prior sponsor, Abbott)
Behavioral study icon
CompletedNCT00937469

Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

Social Skills Training and Standard Treatment Versus Standard Treatment of Children With ADHD - Attention Deficit Hyperactivity Disorder. Attachment Problems Among Children With ADHD

This study has finished and is no longer accepting participants.

In Holbæk
ADHDBehavioural studyAges 8–13
Countries
Denmark
Sponsor
Region Zealand
Drug study icon
CompletedNCT00585910

Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

Official study title

Efficacy and Safety/Tolerability of OROS MPH (Concerta) Plus Atomoxetine (ATMX) in Children and Adolescents (Age 6-17) With Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Cambridge
ADHDMedication studyAges 6–17
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00586157

Medication Patch to Treat Children Ages 6-12 With ADHD

What is this study about?

This study evaluated the safety and effectiveness of Methylphenidate Transdermal System for people with ADHD.

This study has finished and is no longer accepting participants.

In Cambridge
ADHDMedication studyAges 6–12
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.